Organon & Co | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Adcock Ingram Holdings ZAR 5.54B 131.19M 2024-12
Bristol-Myers Squibb USD 17.49B 100M 2025-06
Celltrion KRW 17.14T 298.25B 2025-03
Cspc Pharmaceutical CNY 32.26B 2.59B 2024-12
Dianthus Therapeutics USD 303.08M 49.4M 2025-06
Divis Laboratories Ltd 149.69B 12.52B 2025-03
Gilead Sciences USD 19.67B 596M 2025-06
Glaxosmithkline GBP 14.35B 683M 2025-06
Kangmei Pharma CNY 7.73B 546.26M 2025-06
Knight Therapeutics CAD 773.91M 11.11M 2024-09
Laboratorios Farma EUR 574.72M 6.82M 2025-06
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 55.33M 9.6M 2024-12
Merck USD 49.06B 725M 2025-06
Neuren Pharmaceuticals AUD 363.9M 144.75M 2024-12
Novartis USD 42.05B 1.99B 2025-06
Organigram Holdings CAD 385.5M 61.85M 2025-06
Organon & Co USD 733M 191M 2025-06
Pharma Mar EUR 201.53M 4.06M 2025-06
Qiagen NV USD 3.51B 97.61M 2025-06
Sartorius EUR 2.66B 51.3M 2025-06
Sino Biopharmaceutical CNY 31.96B 884.2M 2024-12
Tilray USD 3.47B 5.16M 2024-11


Organon & Co Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Sep 2025.